Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017)

BACKGROUND: As daily oral pre-exposure prophylaxis (PrEP) becomes standard for HIV prevention, routine use of PrEP is likely to increase within clinical trials of novel preventive agents. We describe the prevalence and characteristics of participants reporting non-study oral PrEP use within Microbic...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Acquir Immune Defic Syndr
Main Authors: Liu, Albert Y., Norwood, Aliza, Gundacker, Holly, Carballo-Diéguez, Alex, Johnson, Sherri, Patterson, Karen, Bekker, Linda-Gail, Chariyalertsak, Suwat, Chitwarakorn, Anupong, Gonzales, Pedro, Holtz, Timothy H., Mayer, Kenneth H., Zorrilla, Carmen, Buchbinder, Susan, Piper, Jeanna M., Lama, Javier R., Cranston, Ross D.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6629432/
https://ncbi.nlm.nih.gov/pubmed/31299013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002066
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker